Ib Leunbach

Molecular imaging with endogenous substances

Dynamic nuclear polarization has enabled hyperpolarization of nuclei such as 13C and 15N in endogenous substances. The resulting high nuclear polarization makes it possible to perform subsecond 13C MRI. By using the dynamic nuclear polarization hyperpolarization technique, 10% polarization was obtained in an aqueous solution of 100 mM 13C-labeled urea, ready for injection. The in vivo T1 relaxation time of 13C in the urea solution was determined to 20 ± 2 s. Due to the long relaxation time, it is possible to use the hyperpolarized substance for medical imaging. A series of high-resolution (≈1-mm) magnetic resonance images were acquired, each with a scan time of 240 ms, 0-5 s after an i.v. injection of the hyperpolarized aqueous [13C]urea solution in a rat. The results show that it is possible to perform 13C angiography with a signal-to-noise ratio of ≈275 in ≈0.25 s. Perfusion studies with endogenous substances may allow higher spatial and/or temporal resolution than is possible with current proton imaging techniques.

Dynamic in vivo oxymetry using overhauser enhanced MR imaging.

A noninvasive method for in vivo measurement of the oxygen concentration has been developed. By introducing a novel contrast medium (CM) based on a single electron substance, it is possible to enhance the proton signal through the Overhauser effect. A low‐field magnetic resonance scanner is used to image the proton nuclei of the object. The electron spin transition of the CM is saturated using rf irradiation. As a consequence, the nuclear polarization becomes enhanced through dipole‐dipole interaction. The signal enhancement is a function of rf power and of the EPR line width of the substance, which is influenced by the oxygen concentration. The maximum in vivo enhancement has been measured to 60. Image data, generated with different scanning parameters, is used in a postprocessing method to generate images showing pO2 and the contrast medium concentration, respectively. The mathematical foundation of the postprocessing algorithm is outlined. The results from phantom experiments and animal experiments, in which the oxygen content of the inspired gas was varied, are presented. The potential for human imaging is discussed. J. Magn. Reson. Imaging 2000;12:929–938.

Overhauser-enhanced MR imaging (OMRI)

Purpose: to evaluate a new single-electron contrast agent for Overhauser-enhanced MR imaging. the contrast agents that are currently available give enhancement factors that are too low to make the technique a valid option for routine clinical use Material and Methods: MR images were generated directly following the injection of the substance into rats. the MR scanner was operated at a main magnetic field of 0.01 T and equipped with a separate rf-transmitter tuned to the electron paramagnetic resonance frequency of the contrast agent Results: as expected, the images generated show a high level of enhancement in areas where the contrast agent was present, and a maximum enhancement of 60 times the normal proton signal was obtained in the vascular area. the signal-to-noise ratios in the images were superior to those previously attained Conclusion: the new contrast agent makes it possible to generate MR images with both morphological and functional information at 0.01 T. the signal-to-noise ratios found in the generated images were of the same order as, or better than, those obtained with the standard clinical routine

MRI contrast media for the liver. Efficacy in conditions of acute biliary obstruction

The authors investigated in a rat model the efficacy of magnetic resonance imaging (MRI) contrast media for evaluating the liver in conditions of acute biliary obstruction. Two liver-specific MRI contrast media, Cr-DEHIDA and Mn-DPDP, and the nonspecific agent Gd-DTPA were studied in normal rats and in rats whose bile ducts had been ligated before administration of the contrast medium. Images were made using a 2.4 T animal MRI system, and intensity enhancement of liver after contrast medium injection was calculated. Metal analyses of serum and liver tissue and T1 and T2 measurements on liver samples in vitro were performed. The differences in image intensity enhancement of liver between normal rats and rats with ligated bile ducts were not significant for any of the three contrast media. Imaging with Mn-DPDP resulted in the highest intensity enhancement of the liver compared with Cr-DEHIDA and Gd-DTPA. Contrast media concentrations in liver tissue were not significantly different between normal rats and rats with ligated bile ducts; however, Cr-DEHIDA concentrations in serum were higher after bile duct ligation. In vitro measurements of liver tissue indicated unique relaxation properties for Mn-DPDP. This investigation indicates that the contrast media studied may be useful in situations where suspected liver pathology is complicated by acute biliary obstruction.

Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging

The invention relates to a modification of electron spin resonance enhanced magnetic resonance imaging (ESREMRI) in which two magnetically responsive materials (contrast agents) are introduced into the sample being investigated, one contrast agent serving as an ESREMRI free induction decay signal enhancing agent and the other as enhancement suppressing agent. In this way, image contrast may be enhanced further for regions in which the suppressing agent distributes poorly or not at all or which the suppressing agent reaches at a later time than the enhancing agent.

Electron spin resonance enhanced MRI using an echo planar imaging technique

There is provided an improved magnetic resonance imaging procedure which essentially combines electron spin resonance enhanced MRI with echo planar imaging MRI.

A magnetic resonance imaging contrast medium for the liver and bile.

Golman K, Klaveness J, Holtz E, Leunbach I, Rye AS, Almén T. A magnetic resonance imaging contrast medium for the liver and bile. Invest Radiol 1988;23(Suppl 1):S243‐S245. A pharmacokinetic investigation of a paramagnetic Cr‐HIDA derivative was performed. Blood, bile, and urine were collected during the first 2 hours after injection of Cr‐HIDA 0.01, 0.05, and 0.25 mmol/kg in rats or rabbits. The pharmacokinetics of the substance were found to be similar to those of the biliary iodinated contrast media in common use. Magnetic resonance imaging performed at 10 minutes after injection into the animals revealed that it was necessary to use doses higher than 0.01 mmol/kg to obtain a diagnostically significant increase in signal intensity from the liver. The gallbladder, however, was clearly defined at this dose level.